|Apatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer|
G Roviello, A Ravelli, K Polom, R Petrioli, L Marano, D Marrelli, F Roviello, ...
Cancer letters 372 (2), 187-191, 2016
|Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review|
FE von Eyben, G Roviello, T Kiljunen, C Uprimny, I Virgolini, K Kairemo, ...
European journal of nuclear medicine and molecular imaging 45 (3), 496-508, 2018
|The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015|
G De Manzoni, D Marrelli, GL Baiocchi, P Morgagni, L Saragoni, ...
Gastric Cancer 20 (1), 20-30, 2017
|Surgical management of advanced gastric cancer: An evolving issue|
L Marano, K Polom, A Patriti, G Roviello, G Falco, A Stracqualursi, ...
European Journal of Surgical Oncology (EJSO) 42 (1), 18-27, 2016
|The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials|
G Roviello, T Bachelot, CA Hudis, G Curigliano, AR Reynolds, R Petrioli, ...
European Journal of Cancer 75, 245-258, 2017
|Meta‐analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer|
K Polom, L Marano, D Marrelli, R De Luca, G Roviello, V Savelli, P Tan, ...
British Journal of Surgery 105 (3), 159-167, 2018
|Strong prognostic value of microsatellite instability in intestinal type non-cardia gastric cancer|
D Marrelli, K Polom, V Pascale, C Vindigni, R Piagnerelli, L De Franco, ...
Annals of surgical oncology 23 (3), 943-950, 2016
|c-Met targeting in advanced gastric cancer: An open challenge|
L Marano, R Chiari, A Fabozzi, F De Vita, V Boccardi, G Roviello, ...
Cancer letters 365 (1), 30-36, 2015
|Apatinib for the treatment of gastric cancer|
G Roviello, A Ravelli, AI Fiaschi, MR Cappelletti, A Gobbi, C Senti, ...
Expert review of gastroenterology & hepatology 10 (8), 887-892, 2016
|Angiogenesis inhibitors in gastric and gastroesophageal junction cancer|
G Roviello, R Petrioli, L Marano, K Polom, D Marrelli, A Perrella, ...
Gastric Cancer 19 (1), 31-41, 2016
|Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of …|
G Roviello, S Sigala, S Sandhu, A Bonetta, MR Cappelletti, L Zanotti, ...
European Journal of Cancer 61, 111-121, 2016
|CEA and CA19. 9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab|
R Petrioli, A Licchetta, G Roviello, A Pascucci, E Francini, G Bargagli, ...
Cancer investigation 30 (1), 65-71, 2012
|The prognostic value of PI3K mutational status in breast cancer: A meta‐analysis|
N Sobhani, G Roviello, SP Corona, M Scaltriti, A Ianza, M Bortul, ...
Journal of cellular biochemistry 119 (6), 4287-4292, 2018
|Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: a systematic review and meta-analysis|
R Petrioli, G Roviello, L Zanotti, F Roviello, K Polom, A Bottini, L Marano, ...
Critical reviews in oncology/hematology 102, 82-88, 2016
|Advances in systemic therapy for metastatic breast cancer: future perspectives|
SP Corona, N Sobhani, A Ianza, G Roviello, G Mustacchi, M Bortul, ...
Medical Oncology 34 (7), 1-16, 2017
|Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer|
N Sobhani, A D’Angelo, M Pittacolo, G Roviello, A Miccoli, SP Corona, ...
Cells 8 (4), 321, 2019
|Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of …|
G Roviello, S Sigala, R Danesi, M Del Re, A Bonetta, MR Cappelletti, ...
Critical Reviews in Oncology/Hematology 101, 12-20, 2016
|No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide|
E Francini, R Petrioli, G Roviello
Expert review of anticancer therapy 14 (10), 1135-1140, 2014
|Current status of fibroblast growth factor receptor-targeted therapies in breast cancer|
N Sobhani, A Ianza, A D’Angelo, G Roviello, F Giudici, M Bortul, ...
Cells 7 (7), 76, 2018
|Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer|
K Polom, G Roviello, D Generali, L Marano, R Petrioli, S Marsili, E Caputo, ...
International Journal of Hyperthermia 32 (3), 298-310, 2016